Collateral for a security interest recorded Jun 7, 2024 (U.S. Bank Trust Company, National Association).
Term ends May 14, 2027 · High confidence
20-year base term ended Sep 27, 2026
Held by Biotissue Holdings Inc.
Filed Sep 27, 2006 as application 11/528,980 · Granted Apr 10, 2012
Base term plus 229 days of patent term adjustment (USPTO delay)
Today
2006
2027
Clock starts
Sep 27, 2006
Sep 27, 2006
Term ends
May 14, 2027
May 14, 2027
Granted
Apr 10, 2012
Apr 10, 2012
base term
patent term adjustment
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
229
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 229 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Sep 27, 2006, when this application, 11/528,980, was filed | Sep 27, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +229 days, USPTO patent term adjustment record | May 14, 2027 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | May 14, 2027 | High confidence |
This family
| US 8,153,162 | this patent May 2027 | May 2027 |
| US 8,460,714 | Term ended Sep 2026 | Sep 2026 |
| US 9,198,939 | Term ended Sep 2026 | Sep 2026 |
| US 9,956,252 | Term ended Sep 2026 | Sep 2026 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Oct 26, 2006 Reel 18450, frame 42 | Tseng, Scheffer; He, Hua; Li, Wei | Bio-Tissue, Inc. | Assignment of Assignor's Interest |
| Nov 29, 2006 Reel 18562, frame 979 | Bio-Tissue, Inc. | Tissuetech, Inc. | Assignment of Assignor's Interest |
| May 18, 2022 Reel 60116, frame 413 | Tissuetech, Inc.; Bio-Tissue, Inc.; Amniox Medical, Inc. | Midcap Financial Trust | Intellectual Property Security Agreement - Term Loan |
| May 18, 2022 Reel 60116, frame 468 | Tissuetech, Inc.; Bio-Tissue, Inc.; Amniox Medical, Inc. | Midcap Funding IV Trust | Intellectual Property Security Agreement - Revolving Loan |
| May 22, 2023 Reel 63713, frame 329 | Tissuetech, Inc. | Biotissue Holdings Inc. | Change of Name |
| Jun 7, 2024 reel/frame not recorded | Midcap Financial Trust | Biotissue Holdings Inc. (F/K/A Tissue Tech, Inc.) | Release of Security Interest |
| Jun 7, 2024 reel/frame not recorded | Midcap Financial Trust | Biotissue Ocular Inc. (F/K/A Bio-Tissue, Inc.) | Release of Security Interest |
| Jun 7, 2024 reel/frame not recorded | Midcap Financial Trust | Biotissue Surgical Inc. (F/K/A Amniox Medical, Inc.) | Release of Security Interest |
| Jun 7, 2024 reel/frame not recorded | Midcap Funding IV Trust | Biotissue Holdings Inc. (F/K/A Tissue Tech, Inc.) | Release of Security Interest |
| Jun 7, 2024 reel/frame not recorded | Midcap Funding IV Trust | Biotissue Ocular Inc. (F/K/A Bio-Tissue, Inc.) | Release of Security Interest |
| Jun 7, 2024 reel/frame not recorded | Midcap Funding IV Trust | Biotissue Surgical Inc. (F/K/A Amniox Medical, Inc.) | Release of Security Interest |
| Jun 7, 2024 Reel 67666, frame 235 | Biotissue Holdings Inc.; Biotissue Ocular Inc.; Biotissue Surgical Inc. | U.S. Bank Trust Company, National Association | Security Interest |
| Jun 7, 2024 Reel 67666, frame 165 | Midcap Financial Trust | Biotissue Holdings Inc. (F/K/A Tissue Tech, Inc.); Biotissue Ocular Inc. (F/K/A Bio-Tissue, Inc.); Biotissue Surgical Inc. (F/K/A Amniox Medical, Inc.) | Release of Security Interest |
| Jun 7, 2024 Reel 67666, frame 200 | Midcap Funding IV Trust | Biotissue Holdings Inc. (F/K/A Tissue Tech, Inc.); Biotissue Ocular Inc. (F/K/A Bio-Tissue, Inc.); Biotissue Surgical Inc. (F/K/A Amniox Medical, Inc.) | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
May 2027
Term ends May 14, 2027. No further fees fall due before then
Note
The 229 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
196
later US patents cite this one
That is top 5% of utility patents granted in 2012 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.